Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early High-Dose Cryoprecipitate in Major Trauma Hemorrhage
NCT04704869Phase 3Completed
- Start
- Jan 2017
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 2
01
Overview
A Phase 3 trial of cryoprecipitate in traumatic hemorrhage. Started Jan 2017; status: completed.
02
Drugs
cryoprecipitate
03
Conditions
traumatic hemorrhage
Beyond the preview
Go deeper on NCT04704869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04704869.